• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Microcirculatory Predictors of Thrombosis in Patients After COVID-19
Introduction: The lack of a history of the course of a new coronavirus infection and the lack of data from randomised trials makes it difficult to choose the right treatment tactics and prescribe adequate prophylaxis in patients who have suffered from COVID-19. Comorbid patients with cardiovascular diseases and endothelial dysfunction have a high risk of a severe course of COVID-19 and subsequent thrombotic complications, which manifest clinically as cardiomyopathy; venous thrombo-embolism (deep vein thrombosis and pulmonary embolism); pulmonary thrombosis in situ; stroke; arterial thrombangiitis; rarely, arterial peripher...
Source: EJVES Extra - March 23, 2022 Category: Surgery Authors: Yulia Andozhskaya Source Type: research

Cardiovascular and Cerebrovascular Complications With COVID-19
The coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus-2 has affected the health of people across the globe. Cardiovascular diseases (CVDs) have a significant relationship with COVID-19, both as a risk factor and prognostic indicator, and as a complication of the disease itself. In addition to predisposing to CVD complications, the ongoing pandemic has severely affected the delivery of timely and appropriate care for cardiovascular conditions resulting in increased mortality. The etiology behind the cardiac injury associated with severe acute respiratory syndrome coronavirus-2 i...
Source: Cardiology in Review - April 17, 2021 Category: Cardiology Tags: Review Articles Source Type: research

Stroke Care during the COVID-19 Pandemic: International Expert Panel Review
This study, prepared by a large international panel of stroke experts, assesses the rapidly growing research and personal experience with COVID-19 stroke and offers recommendations for stroke management in this challenging new setting: modifications needed for prehospital emergency rescue and hyperacute care; inpatient intensive or stroke units; posthospitalization rehabilitation; follow-up including at-risk family and community; and multispecialty departmental developments in the allied professions.Summary: The severe acute respiratory syndrome coronavirus 2 uses spike proteins binding to tissue angiotensin-converting enz...
Source: Cerebrovascular Diseases - March 23, 2021 Category: Neurology Source Type: research

Large cerebellar stroke in a young COVID-19 positive patient
Coronavirus Disease 2019 (COVID-19), caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), most frequently presents with respiratory symptoms such as fever, dyspnea, shortness of breath, cough, or myalgias. There is now a growing body of evidence that demonstrates that severe SARS-CoV-2 infections can develop clinically significant coagulopathy, inflammation, and cardiomyopathy, which have been implicated in COVID-19 associated cerebrovascular accidents (CVAs).
Source: The Journal of Emergency Medicine - February 9, 2021 Category: Emergency Medicine Authors: Faith Quenzer, Cameron Smyres, Norma Tabarez, Sukhdeep Singh, Andrew LaFree, Christian Tomaszewski, Stephen R. Hayden Tags: Selected Topics: Neurological Emergencies Source Type: research

Large Cerebellar Stroke in a Young COVID-19 –Positive Patient: Case Report
Coronavirus disease 2019 (COVID-19), caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), most frequently presents with respiratory symptoms, such as fever, dyspnea, shortness of breath, cough, or myalgias. There is now a growing body of evidence that demonstrates that severe SARS-CoV-2 infections can develop clinically significant coagulopathy, inflammation, and cardiomyopathy, which have been implicated in COVID-19 –associated cerebrovascular accidents (CVAs).
Source: The Journal of Emergency Medicine - February 9, 2021 Category: Emergency Medicine Authors: Faith Quenzer, Cameron Smyres, Norma Tabarez, Sukhdeep Singh, Andrew LaFree, Christian Tomaszewski, Stephen R. Hayden Tags: Selected Topics: Neurological Emergencies Source Type: research

Pharmacological and cardiovascular perspectives on the treatment of COVID-19 with chloroquine derivatives.
Abstract The novel severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19) and an ongoing severe pandemic. Curative drugs specific for COVID-19 are currently lacking. Chloroquine phosphate and its derivative hydroxychloroquine, which have been used in the treatment and prevention of malaria and autoimmune diseases for decades, were found to inhibit SARS-CoV-2 infection with high potency in vitro and have shown clinical and virologic benefits in COVID-19 patients. Therefore, chloroquine phosphate was first used in the treatment of COVID-19 in China. Later, under a lim...
Source: Acta Pharmacologica Sinica - September 22, 2020 Category: Drugs & Pharmacology Authors: Zhang XL, Li ZM, Ye JT, Lu J, Ye LL, Zhang CX, Liu PQ, Duan DD Tags: Acta Pharmacol Sin Source Type: research

Letter in Response to Article in Journal of Infection: “Cardiovascular complications in COVID-19: A systematic review and meta-analysis”
We read with great interest the systematic review and meta-analysis by Kunutsor and Laukkanen, which was recently published in the Journal of Infection and attempted to investigate the cardiovascular complications of coronavirus disease 2019 (COVID-19) [1]. The authors investigated and reported the pooled incidence for cardiac arrhythmia, heart failure, cardiomyopathy, disseminated intravascular coagulation, cardiac arrest, acute coronary syndrome, stroke, and among these pulmonary embolism (PE) and venous thromboembolism (VTE).
Source: Journal of Infection - June 29, 2020 Category: Infectious Diseases Authors: Dimitrios Giannis, Ioannis A. Ziogas Tags: Letter to the Editor Source Type: research